Additional services from select pharmacies – information for pharmacists

​ºÚÁϳԹÏÍø Health has also authorised individual pharmacists who have successfully completed specified university-level training available through the Queensland University of Technology and James Cook University to provide treatment to eligible people for:​

  • Hormonal contraception resupply​
  • Urinary tract infection (UTI) management
  • Mild, acute musculoskeletal pain
  • Gastro-oesophageal reflux and gastro-oesophageal reflux disease (GORD)
  • Allergic and non-allergic rhinitis

​Queensland-trained pharmacists offering these services must first complete the Intention to provide expanded community pharmacy services in ºÚÁϳԹÏÍø​ form. 

All services in ºÚÁϳԹÏÍø must be delivered in accordance with the relevant ºÚÁϳԹÏÍø Authorities Practice Standards.

On this page

Ph​armacist requirements​

Pharmacists who have successfully completed the specified â€‹university-level training available through the Queensland University of Technology and James Cook University, who intend to offer these services in ºÚÁϳԹÏÍø must complete Intention to provide expanded community pharmacy services in ºÚÁϳԹÏÍø form. The form must be resubmitted with updates if your details change (such as place of practice).

All pharmacists and pharmacies providing these services must meet the requirements of and operate in accordance with the relevant ºÚÁϳԹÏÍø Authorities and Practice Standards.

Please note, eligible pharmacists in ºÚÁϳԹÏÍø can offer services for urinary tract infection management, hormonal contraception resupply, and under the ºÚÁϳԹÏÍø Pharmacy Trial, minor skin condition management. Pharmacists who have completed the ºÚÁϳԹÏÍø-based training for these services do not need to complete the form before they commence practice. 

​Read the ºÚÁϳԹÏÍø Authorities and Practice Standards to ensure compliance:

Key requirements for pharmacists and pharmacies include:

  • Completing mandatory approved training (as listed in relevant Authorities)
  • Sharing a record of supply with the patient's usual treating medical practitioner or medical practice, where the patient has one, following consent by the patient. This must be shared within a week following the consultation
  • Appropriate private areas available to conduct consultations
  • Maintaining secure digital records of all consultations and their outcomes
  • Maintaining up-to-date service listings via the healthdirect, also known as the National Health Services Directory​ .​

Eligible patients

Specific eligibility criteria are in place to ensure patients receive safe and appropriate care. These requirements are particular to each condition:

Creating and maintaining your service listing on healthdirect

Pharmacies who provide the service are responsible for maintaining their own up-to-date service listings via the National Health Services Directory (±·±á³§¶Ù)​​.

First, check if your pharmacy has already been listed with the NHSD.

If you have an existing listing, you can update this by emailing amendments to the NHSD team. Please notify them in your email that you would like to include the specific service offering.

If you do not have a listing, to register your pharmacy with the NHSD, complete the online registration form​. When the NHSD team contacts you, please notify them that you would like to include any of the above service offerings at your pharmacy.​

Cost of​ service

Pharmacists can charge a consultation fee for patients seeking these services. This is at the discretion of the pharmacy.

This consultation fee will be in addition to the cost of any medicines supplied.

More inform​ation

Pharmacists should reach out to their member organisations in the first instance for further advice and support regarding service provision.

For general information, pharmacists should contact ºÚÁϳԹÏÍø Health at MOH-communitypharmacyscope@health.nsw.gov.au. ​

Pharmacies may promote the service offering using their own developed materials in accordance with relevant guidelines. Refer to Advertising health services | Therapeutic Goods Administration​.​

Current as at: Friday 28 February 2025
Contact page owner: Pharmaceutical Services